[Frequency and possible reasons for the loss of response to biological therapy in Crohn's disease after a one-year treatment period].

Molnár, Tamás; Farkas, Klaudia; Nyári, Tibor; Szepes, Zoltán; Nagy, Ferenc; Kiss, Tamás; Wittmann, Tibor

[Frequency and possible reasons for the loss of response to biological therapy in Crohn's disease after a one-year treatment period]. / A hatásvesztés gyakorisága és lehetséges okai Crohn-betegség egyéves biológiai kezelése során.

Molnár, Tamás; Farkas, Klaudia; Nyári, Tibor; Szepes, Zoltán; Nagy, Ferenc; Kiss, Tamás; Wittmann, Tibor.

Affiliation

Molnár T; Szegedi Tudományegyetem, Általános Orvostudományi Kar I. Belgyógyászati Klinika Szeged Korányi fasor 8-10. 6720. mot@in1st.szote.u-szeged.hu

Orv Hetil ; 152(24): 951-7, 2011 Jun 12.

Article in Hu | MEDLINE | ID: mdl-21609921

Subject(s)

Anti-Inflammatory Agents/therapeutic use; Antibodies, Monoclonal/therapeutic use; Biological Therapy/methods; Crohn Disease/drug therapy; Drug Tolerance; Gastrointestinal Agents/therapeutic use; Adalimumab; Adolescent; Adult; Anti-Inflammatory Agents/administration & dosage; Antibodies, Monoclonal/administration & dosage; Antibodies, Monoclonal, Humanized; Chi-Square Distribution; Dose-Response Relationship, Drug; Female; Gastrointestinal Agents/administration & dosage; Humans; Infliximab; Kaplan-Meier Estimate; Male; Middle Aged; Remission Induction; Risk Factors; Treatment Outcome; Young Adult

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Biological Therapy / Gastrointestinal Agents / Crohn Disease / Drug Tolerance / Anti-Inflammatory Agents / Antibodies, Monoclonal Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Language: Hu Journal: Orv Hetil Year: 2011 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google